Global Biologic Products Market Research Report 2023
Global Biologic Products Market Overview:
Global Biologic Products Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Biologic Products involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biologic Products Market
The Biologic Products Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Biologic Products Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biologic Products Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Biologic Products Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Products market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Biologic Products Market Segmentation
Global Biologic Products Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Biologic Products market has been segmented into:
Platelet Rich Plasma
Interleukin Receptor Antagonist Protein
Hyaluronic Acid
Others
By Application, Biologic Products market has been segmented into:
Hospitals
Clinics
Diagnostic Centers
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biologic Products market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biologic Products market.
Top Key Players Covered in Biologic Products market are:
Addgene
Celltrion
Samsung Biologics
Eli Lilly & Company
Pfizer Inc.
Amgen
Novo Nordisk AS
Sanofi
Abbvie Inc.
Johnson & Johnson Services Inc.
F Hoffman La Roche
Merck & Co. Inc
Objective to buy this Report:
1. Biologic Products analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biologic Products market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Biologic Products Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Biologic Products involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biologic Products Market
The Biologic Products Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Biologic Products Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biologic Products Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Biologic Products Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Products market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Biologic Products Market Segmentation
Global Biologic Products Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Biologic Products market has been segmented into:
Platelet Rich Plasma
Interleukin Receptor Antagonist Protein
Hyaluronic Acid
Others
By Application, Biologic Products market has been segmented into:
Hospitals
Clinics
Diagnostic Centers
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biologic Products market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biologic Products market.
Top Key Players Covered in Biologic Products market are:
Addgene
Celltrion
Samsung Biologics
Eli Lilly & Company
Pfizer Inc.
Amgen
Novo Nordisk AS
Sanofi
Abbvie Inc.
Johnson & Johnson Services Inc.
F Hoffman La Roche
Merck & Co. Inc
Objective to buy this Report:
1. Biologic Products analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biologic Products market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: BIOLOGIC PRODUCTS MARKET BY TYPE
5.1 Biologic Products Market Overview Snapshot and Growth Engine
5.2 Biologic Products Market Overview
5.3 Platelet Rich Plasma
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Platelet Rich Plasma: Geographic Segmentation
5.4 Interleukin Receptor Antagonist Protein
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Interleukin Receptor Antagonist Protein: Geographic Segmentation
5.5 Hyaluronic Acid
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Hyaluronic Acid: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
CHAPTER 6: BIOLOGIC PRODUCTS MARKET BY APPLICATION
6.1 Biologic Products Market Overview Snapshot and Growth Engine
6.2 Biologic Products Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation
6.5 Diagnostic Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Diagnostic Centers: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biologic Products Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biologic Products Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biologic Products Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ADDGENE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CELLTRION
7.4 SAMSUNG BIOLOGICS
7.5 ELI LILLY & COMPANY
7.6 PFIZER INC.
7.7 AMGEN
7.8 NOVO NORDISK AS
7.9 SANOFI
7.10 ABBVIE INC.
7.11 JOHNSON & JOHNSON SERVICES INC.
7.12 F HOFFMAN LA ROCHE
7.13 MERCK & CO. INC
CHAPTER 8: GLOBAL BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Platelet Rich Plasma
8.2.2 Interleukin Receptor Antagonist Protein
8.2.3 Hyaluronic Acid
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Diagnostic Centers
8.3.4 Others
CHAPTER 9: NORTH AMERICA BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Platelet Rich Plasma
9.4.2 Interleukin Receptor Antagonist Protein
9.4.3 Hyaluronic Acid
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Clinics
9.5.3 Diagnostic Centers
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Platelet Rich Plasma
10.4.2 Interleukin Receptor Antagonist Protein
10.4.3 Hyaluronic Acid
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Clinics
10.5.3 Diagnostic Centers
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Platelet Rich Plasma
11.4.2 Interleukin Receptor Antagonist Protein
11.4.3 Hyaluronic Acid
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Clinics
11.5.3 Diagnostic Centers
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Platelet Rich Plasma
12.4.2 Interleukin Receptor Antagonist Protein
12.4.3 Hyaluronic Acid
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Clinics
12.5.3 Diagnostic Centers
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Platelet Rich Plasma
13.4.2 Interleukin Receptor Antagonist Protein
13.4.3 Hyaluronic Acid
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Clinics
13.5.3 Diagnostic Centers
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: BIOLOGIC PRODUCTS MARKET BY TYPE
5.1 Biologic Products Market Overview Snapshot and Growth Engine
5.2 Biologic Products Market Overview
5.3 Platelet Rich Plasma
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Platelet Rich Plasma: Geographic Segmentation
5.4 Interleukin Receptor Antagonist Protein
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Interleukin Receptor Antagonist Protein: Geographic Segmentation
5.5 Hyaluronic Acid
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Hyaluronic Acid: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
CHAPTER 6: BIOLOGIC PRODUCTS MARKET BY APPLICATION
6.1 Biologic Products Market Overview Snapshot and Growth Engine
6.2 Biologic Products Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation
6.5 Diagnostic Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Diagnostic Centers: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biologic Products Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biologic Products Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biologic Products Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ADDGENE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CELLTRION
7.4 SAMSUNG BIOLOGICS
7.5 ELI LILLY & COMPANY
7.6 PFIZER INC.
7.7 AMGEN
7.8 NOVO NORDISK AS
7.9 SANOFI
7.10 ABBVIE INC.
7.11 JOHNSON & JOHNSON SERVICES INC.
7.12 F HOFFMAN LA ROCHE
7.13 MERCK & CO. INC
CHAPTER 8: GLOBAL BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Platelet Rich Plasma
8.2.2 Interleukin Receptor Antagonist Protein
8.2.3 Hyaluronic Acid
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Diagnostic Centers
8.3.4 Others
CHAPTER 9: NORTH AMERICA BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Platelet Rich Plasma
9.4.2 Interleukin Receptor Antagonist Protein
9.4.3 Hyaluronic Acid
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Clinics
9.5.3 Diagnostic Centers
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Platelet Rich Plasma
10.4.2 Interleukin Receptor Antagonist Protein
10.4.3 Hyaluronic Acid
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Clinics
10.5.3 Diagnostic Centers
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Platelet Rich Plasma
11.4.2 Interleukin Receptor Antagonist Protein
11.4.3 Hyaluronic Acid
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Clinics
11.5.3 Diagnostic Centers
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Platelet Rich Plasma
12.4.2 Interleukin Receptor Antagonist Protein
12.4.3 Hyaluronic Acid
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Clinics
12.5.3 Diagnostic Centers
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA BIOLOGIC PRODUCTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Platelet Rich Plasma
13.4.2 Interleukin Receptor Antagonist Protein
13.4.3 Hyaluronic Acid
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Clinics
13.5.3 Diagnostic Centers
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIOLOGIC PRODUCTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIOLOGIC PRODUCTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIOLOGIC PRODUCTS MARKET COMPETITIVE RIVALRY
TABLE 005. BIOLOGIC PRODUCTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIOLOGIC PRODUCTS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIOLOGIC PRODUCTS MARKET BY TYPE
TABLE 008. PLATELET RICH PLASMA MARKET OVERVIEW (2016-2028)
TABLE 009. INTERLEUKIN RECEPTOR ANTAGONIST PROTEIN MARKET OVERVIEW (2016-2028)
TABLE 010. HYALURONIC ACID MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. BIOLOGIC PRODUCTS MARKET BY APPLICATION
TABLE 013. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 014. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 015. DIAGNOSTIC CENTERS MARKET OVERVIEW (2016-2028)
TABLE 016. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 019. N BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 022. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 025. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 028. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 031. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 032. ADDGENE: SNAPSHOT
TABLE 033. ADDGENE: BUSINESS PERFORMANCE
TABLE 034. ADDGENE: PRODUCT PORTFOLIO
TABLE 035. ADDGENE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. CELLTRION: SNAPSHOT
TABLE 036. CELLTRION: BUSINESS PERFORMANCE
TABLE 037. CELLTRION: PRODUCT PORTFOLIO
TABLE 038. CELLTRION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. SAMSUNG BIOLOGICS: SNAPSHOT
TABLE 039. SAMSUNG BIOLOGICS: BUSINESS PERFORMANCE
TABLE 040. SAMSUNG BIOLOGICS: PRODUCT PORTFOLIO
TABLE 041. SAMSUNG BIOLOGICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. ELI LILLY & COMPANY: SNAPSHOT
TABLE 042. ELI LILLY & COMPANY: BUSINESS PERFORMANCE
TABLE 043. ELI LILLY & COMPANY: PRODUCT PORTFOLIO
TABLE 044. ELI LILLY & COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. PFIZER INC.: SNAPSHOT
TABLE 045. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 046. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 047. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. AMGEN: SNAPSHOT
TABLE 048. AMGEN: BUSINESS PERFORMANCE
TABLE 049. AMGEN: PRODUCT PORTFOLIO
TABLE 050. AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. NOVO NORDISK AS: SNAPSHOT
TABLE 051. NOVO NORDISK AS: BUSINESS PERFORMANCE
TABLE 052. NOVO NORDISK AS: PRODUCT PORTFOLIO
TABLE 053. NOVO NORDISK AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. SANOFI: SNAPSHOT
TABLE 054. SANOFI: BUSINESS PERFORMANCE
TABLE 055. SANOFI: PRODUCT PORTFOLIO
TABLE 056. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ABBVIE INC.: SNAPSHOT
TABLE 057. ABBVIE INC.: BUSINESS PERFORMANCE
TABLE 058. ABBVIE INC.: PRODUCT PORTFOLIO
TABLE 059. ABBVIE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. JOHNSON & JOHNSON SERVICES INC.: SNAPSHOT
TABLE 060. JOHNSON & JOHNSON SERVICES INC.: BUSINESS PERFORMANCE
TABLE 061. JOHNSON & JOHNSON SERVICES INC.: PRODUCT PORTFOLIO
TABLE 062. JOHNSON & JOHNSON SERVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. F HOFFMAN LA ROCHE: SNAPSHOT
TABLE 063. F HOFFMAN LA ROCHE: BUSINESS PERFORMANCE
TABLE 064. F HOFFMAN LA ROCHE: PRODUCT PORTFOLIO
TABLE 065. F HOFFMAN LA ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MERCK & CO. INC: SNAPSHOT
TABLE 066. MERCK & CO. INC: BUSINESS PERFORMANCE
TABLE 067. MERCK & CO. INC: PRODUCT PORTFOLIO
TABLE 068. MERCK & CO. INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIOLOGIC PRODUCTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIOLOGIC PRODUCTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIOLOGIC PRODUCTS MARKET COMPETITIVE RIVALRY
TABLE 005. BIOLOGIC PRODUCTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIOLOGIC PRODUCTS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIOLOGIC PRODUCTS MARKET BY TYPE
TABLE 008. PLATELET RICH PLASMA MARKET OVERVIEW (2016-2028)
TABLE 009. INTERLEUKIN RECEPTOR ANTAGONIST PROTEIN MARKET OVERVIEW (2016-2028)
TABLE 010. HYALURONIC ACID MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. BIOLOGIC PRODUCTS MARKET BY APPLICATION
TABLE 013. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 014. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 015. DIAGNOSTIC CENTERS MARKET OVERVIEW (2016-2028)
TABLE 016. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 019. N BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 022. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 025. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 028. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA BIOLOGIC PRODUCTS MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA BIOLOGIC PRODUCTS MARKET, BY APPLICATION (2016-2028)
TABLE 031. BIOLOGIC PRODUCTS MARKET, BY COUNTRY (2016-2028)
TABLE 032. ADDGENE: SNAPSHOT
TABLE 033. ADDGENE: BUSINESS PERFORMANCE
TABLE 034. ADDGENE: PRODUCT PORTFOLIO
TABLE 035. ADDGENE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. CELLTRION: SNAPSHOT
TABLE 036. CELLTRION: BUSINESS PERFORMANCE
TABLE 037. CELLTRION: PRODUCT PORTFOLIO
TABLE 038. CELLTRION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. SAMSUNG BIOLOGICS: SNAPSHOT
TABLE 039. SAMSUNG BIOLOGICS: BUSINESS PERFORMANCE
TABLE 040. SAMSUNG BIOLOGICS: PRODUCT PORTFOLIO
TABLE 041. SAMSUNG BIOLOGICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. ELI LILLY & COMPANY: SNAPSHOT
TABLE 042. ELI LILLY & COMPANY: BUSINESS PERFORMANCE
TABLE 043. ELI LILLY & COMPANY: PRODUCT PORTFOLIO
TABLE 044. ELI LILLY & COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. PFIZER INC.: SNAPSHOT
TABLE 045. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 046. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 047. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. AMGEN: SNAPSHOT
TABLE 048. AMGEN: BUSINESS PERFORMANCE
TABLE 049. AMGEN: PRODUCT PORTFOLIO
TABLE 050. AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. NOVO NORDISK AS: SNAPSHOT
TABLE 051. NOVO NORDISK AS: BUSINESS PERFORMANCE
TABLE 052. NOVO NORDISK AS: PRODUCT PORTFOLIO
TABLE 053. NOVO NORDISK AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. SANOFI: SNAPSHOT
TABLE 054. SANOFI: BUSINESS PERFORMANCE
TABLE 055. SANOFI: PRODUCT PORTFOLIO
TABLE 056. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ABBVIE INC.: SNAPSHOT
TABLE 057. ABBVIE INC.: BUSINESS PERFORMANCE
TABLE 058. ABBVIE INC.: PRODUCT PORTFOLIO
TABLE 059. ABBVIE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. JOHNSON & JOHNSON SERVICES INC.: SNAPSHOT
TABLE 060. JOHNSON & JOHNSON SERVICES INC.: BUSINESS PERFORMANCE
TABLE 061. JOHNSON & JOHNSON SERVICES INC.: PRODUCT PORTFOLIO
TABLE 062. JOHNSON & JOHNSON SERVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. F HOFFMAN LA ROCHE: SNAPSHOT
TABLE 063. F HOFFMAN LA ROCHE: BUSINESS PERFORMANCE
TABLE 064. F HOFFMAN LA ROCHE: PRODUCT PORTFOLIO
TABLE 065. F HOFFMAN LA ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MERCK & CO. INC: SNAPSHOT
TABLE 066. MERCK & CO. INC: BUSINESS PERFORMANCE
TABLE 067. MERCK & CO. INC: PRODUCT PORTFOLIO
TABLE 068. MERCK & CO. INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIOLOGIC PRODUCTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIOLOGIC PRODUCTS MARKET OVERVIEW BY TYPE
FIGURE 012. PLATELET RICH PLASMA MARKET OVERVIEW (2016-2028)
FIGURE 013. INTERLEUKIN RECEPTOR ANTAGONIST PROTEIN MARKET OVERVIEW (2016-2028)
FIGURE 014. HYALURONIC ACID MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. BIOLOGIC PRODUCTS MARKET OVERVIEW BY APPLICATION
FIGURE 017. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 018. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 019. DIAGNOSTIC CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIOLOGIC PRODUCTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIOLOGIC PRODUCTS MARKET OVERVIEW BY TYPE
FIGURE 012. PLATELET RICH PLASMA MARKET OVERVIEW (2016-2028)
FIGURE 013. INTERLEUKIN RECEPTOR ANTAGONIST PROTEIN MARKET OVERVIEW (2016-2028)
FIGURE 014. HYALURONIC ACID MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. BIOLOGIC PRODUCTS MARKET OVERVIEW BY APPLICATION
FIGURE 017. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 018. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 019. DIAGNOSTIC CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA BIOLOGIC PRODUCTS MARKET OVERVIEW BY COUNTRY (2016-2028)
